免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

NEUROShield

K号: K220034 · 2023-09-14

决定日期2023-09-14
产品代码LLZ
咨询委员会RA
决定实质等同

器械摘要

NEUROShield is the device name listed in this FDA 510(k) record. The listed applicant is In-Med Prognostics L3c. It received FDA 510(k) clearance on 2023-09-14 under 510(k) number K220034. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the NEUROShield?

NEUROShield is a medical device that received FDA 510(k) clearance on 2023-09-14. The listed applicant is In-Med Prognostics L3c. The 510(k) number is K220034.

When did NEUROShield receive FDA 510(k) clearance?

NEUROShield received FDA 510(k) clearance on 2023-09-14, under 510(k) number K220034.

Who is the listed applicant for NEUROShield?

The FDA 510(k) record lists In-Med Prognostics L3c as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NEUROShield?

The FDA product code for NEUROShield is LLZ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:LLZ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑